P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP

• P. Ghia,
• A. Pluta,
• M. Wach,
• D. Lysak,
• M. Simkovic,
• I. Kriachok,
• A. Illes,
• J. de la Serna,
• S. Dolan,
• P. Campbell,
• G. Musuraca,
• A. Jacob,
• E. Avery,
• J. H. Lee,
• G. Usenko,
• M. H. Wang,
• T. Yu,
• W. Jurczak

Affiliations

P. Ghia

1 Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, Italy

A. Pluta

2 Department of Hematological Oncology, Oncology Specialist Hospital, Brzozow

M. Wach

3 Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland

D. Lysak

4 Fakultní Nemocnice Plzen, Pilsen

M. Simkovic

5 University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czechia

I. Kriachok

6 National Cancer Institute, Kiev, Ukraine

A. Illes

7 University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary

J. de la Serna

8 Hospital Universitario 12 de Octubre, Madrid, Spain

S. Dolan

9 Saint John Regional Hospital, University of New Brunswick, New Brunswick, Canada

P. Campbell

10 Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia

G. Musuraca

11 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy

A. Jacob

12 The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom

E. Avery

13 Nebraska Hematology Oncology, Lincoln, Nebraska, United States of America

J. H. Lee

14 Gachon University Gil Medical Center, Incheon, South Korea

G. Usenko

15 City Clinical Hospital No. 4 DCC, Dnipro, Ukraine

M. H. Wang

16 AstraZeneca, South San Francisco, California

T. Yu

17 AstraZeneca, South San Francisco, California, United States of America

W. Jurczak

18 Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland